PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25449038-5	2015	Hinokitiol appeared to achieve this effect by reducing the expression of MMP-1 and by suppressing the phosphorylation of mitogen- activated protein kinase (MAPK) signaling molecules such as extracellular signal-regulated kinase (ERK) 1/2, p38 MAPK and c-Jun N-terminal kinases (JNK).	beta-thujaplicin	0-10	matrix metallopeptidase 13	Mus musculus	73-78	
25449038-5	2015	Hinokitiol appeared to achieve this effect by reducing the expression of MMP-1 and by suppressing the phosphorylation of mitogen- activated protein kinase (MAPK) signaling molecules such as extracellular signal-regulated kinase (ERK) 1/2, p38 MAPK and c-Jun N-terminal kinases (JNK).	beta-thujaplicin	0-10	mitogen-activated protein kinase 1	Mus musculus	156-160	
25449038-5	2015	Hinokitiol appeared to achieve this effect by reducing the expression of MMP-1 and by suppressing the phosphorylation of mitogen- activated protein kinase (MAPK) signaling molecules such as extracellular signal-regulated kinase (ERK) 1/2, p38 MAPK and c-Jun N-terminal kinases (JNK).	beta-thujaplicin	0-10	mitogen-activated protein kinase 3	Mus musculus	190-237	
25449038-5	2015	Hinokitiol appeared to achieve this effect by reducing the expression of MMP-1 and by suppressing the phosphorylation of mitogen- activated protein kinase (MAPK) signaling molecules such as extracellular signal-regulated kinase (ERK) 1/2, p38 MAPK and c-Jun N-terminal kinases (JNK).	beta-thujaplicin	0-10	mitogen-activated protein kinase 14	Mus musculus	239-247	
25449038-5	2015	Hinokitiol appeared to achieve this effect by reducing the expression of MMP-1 and by suppressing the phosphorylation of mitogen- activated protein kinase (MAPK) signaling molecules such as extracellular signal-regulated kinase (ERK) 1/2, p38 MAPK and c-Jun N-terminal kinases (JNK).	beta-thujaplicin	0-10	jun proto-oncogene	Mus musculus	252-257	
25449038-6	2015	On the other hand, hinokitiol treatment reversed IkappaB-alpha degradation and inhibited the phosphorylation of p65 nuclear factor kappa B (NF-kappaB) and cJun in B16-F10 cells.	beta-thujaplicin	19-29	nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha	Mus musculus	49-62	
25449038-6	2015	On the other hand, hinokitiol treatment reversed IkappaB-alpha degradation and inhibited the phosphorylation of p65 nuclear factor kappa B (NF-kappaB) and cJun in B16-F10 cells.	beta-thujaplicin	19-29	jun proto-oncogene	Mus musculus	155-159	
25449038-7	2015	In addition, hinokitiol suppressed the translocation of p65 NF-kappaB from the cytosol to the nucleus, suggesting reduced NF-kappaB activation.	beta-thujaplicin	13-23	v-rel reticuloendotheliosis viral oncogene homolog A (avian)	Mus musculus	56-69